ArticleJournal of translational medicine2024

CAPN2 promotes apalutamide resistance in metastatic hormone-sensitive prostate cancer by activating protective autophagy.

Zihao Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.